Tci Gene (ROCO:6879) EV-to-EBITDA : 44.71 (As of May. 22, 2024)

Tci Gene EV-to-EBITDA Chart

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial				-	-	18.14	-	51.77

Competitive Comparison of Tci Gene's EV-to-EBITDA

For the Biotechnology subindustry, Tci Gene's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tci Gene's EV-to-EBITDA falls into.

Tci Gene EV-to-EBITDA Calculation

Tci Gene's EV-to-EBITDA for today is calculated as:

Tci Gene's current Enterprise Value is NT$1,157.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tci Gene's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$25.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tci Gene  (ROCO:6879) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Tci Gene's PE Ratio for today is calculated as:

Tci Gene's share price for today is NT$77.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tci Gene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.440.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Tci Gene EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tci Gene's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description